Ruglass Lesia M, Pedersen Annelisa, Cheref Soumia, Hu Mei-Chen, Hien Denise A
a Department of Psychology , City College of New York of CUNY , New York , NY.
b Department of Psychology , University of Houston , Houston , TX.
J Ethn Subst Abuse. 2016 Oct-Dec;15(4):434-448. doi: 10.1080/15332640.2015.1056927. Epub 2015 Sep 30.
We conducted a secondary data analysis to examine whether there were racial differences in adherence and treatment outcomes for participants with co-occurring full and subthreshold post-traumatic stress disorder (PTSD) and alcohol/substance use disorders (A/SUD) who were treated with Seeking Safety (a cognitive-behavioral therapy) and sertraline or Seeking Safety and placebo as part of a clinical trial. Bivarate analyses examined the association between race and adherence, and generalized estimating equations assessed whether race moderated the effect of combination treatment on PTSD and alcohol use outcomes. Except for education, there were no statistically significant racial differences in baseline demographic and psychiatric characteristics. African Americans and Caucasians were equally adherent in number of psychotherapy and medication sessions attended and medication compliance. After controlling for baseline demographics and psychiatric symptoms, however, a race by treatment condition interaction emerged suggesting that African Americans who received the Seeking Safety and sertraline treatment had significantly lower PTSD symptom severity posttreatment and at six months follow-up compared to their counterparts who received Seeking Safety and placebo. No differential effect of treatment condition was found for Caucasians. Moreover, results indicated that a diagnosis of major depressive disorder negatively impacted PTSD symptom recovery for African American participants but not for Caucasians. In conclusion, no differences emerged between African Americans and Caucasians in adherence to combination treatments for PTSD and A/SUD. Findings also suggest assessment and treatment of MDD among African Americans may improve treatment outcomes. More research is needed to determine whether the differential response to Seeking Safety and sertraline among African Americans compared to Caucasians can be replicated.
我们进行了一项二次数据分析,以检验在一项临床试验中,同时患有完全型和亚阈值创伤后应激障碍(PTSD)及酒精/物质使用障碍(A/SUD)的参与者,接受“寻求安全”(一种认知行为疗法)与舍曲林联合治疗或“寻求安全”与安慰剂联合治疗时,在依从性和治疗结果方面是否存在种族差异。双变量分析检验了种族与依从性之间的关联,广义估计方程评估了种族是否调节联合治疗对PTSD和酒精使用结果的影响。除教育程度外,基线人口统计学和精神病学特征方面不存在统计学上显著的种族差异。非裔美国人和白人在参加心理治疗和药物治疗的次数以及药物依从性方面的人数相同。然而,在控制了基线人口统计学和精神症状后,出现了种族与治疗条件的交互作用,这表明接受“寻求安全”与舍曲林治疗的非裔美国人在治疗后和六个月随访时的PTSD症状严重程度显著低于接受“寻求安全”与安慰剂治疗的同龄人。未发现白人在治疗条件上有差异影响。此外,结果表明,重度抑郁症的诊断对非裔美国参与者的PTSD症状恢复有负面影响,但对白人没有影响。总之,非裔美国人和白人在对PTSD和A/SUD联合治疗的依从性方面没有差异。研究结果还表明,对非裔美国人的重度抑郁症进行评估和治疗可能会改善治疗结果。需要更多研究来确定非裔美国人与白人相比对“寻求安全”和舍曲林的不同反应是否可以重复。